PAM
ELEV

Panagora Asset Management’s Elevation Oncology ELEV Stock Holding History

Panagora Asset Management’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-63,547
Closed -$16.5K – 1137
2025
Q1 		$16.5K Buy
+63,547
New +$36.3K ﹤0.01% 1096

Other funds holding ELEV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Panagora Asset Management's ELEV Position: Q2 2025 in Review

Panagora Asset Management sold out of Elevation Oncology (ELEV) in Q2 2025, closing a stake of 63,547 shares — an estimated $16.5K sold.

Panagora Asset Management first reported a position in ELEV in Q1 2025 and held it in 1 quarter. The position peaked at $16.5K in Q1 2025. 65 funds tracked by Wall St. Rank hold ELEV as of Q2 2025.

  • Panagora Asset Management reported no remaining Elevation Oncology position as of Q2 2025 after selling out during the quarter.
  • Panagora Asset Management sold 63,547 Elevation Oncology shares in Q2 2025, an estimated $16.5K.
  • Panagora Asset Management first reported a position in Elevation Oncology in Q1 2025 and held it in 1 quarter.
  • Panagora Asset Management's Elevation Oncology position peaked at $16.5K in Q1 2025.
  • 65 funds tracked by Wall St. Rank held Elevation Oncology as of Q2 2025.

Based on Panagora Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.